Stock data
Impact BioMedical, Inc. (IBO)
Impact BioMedical, Inc. (IBO) reported revenue of US$0.03M and net income of -US$11.84M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$0.03M | — | -US$4.28M | -US$11.84M | — |
| 2024 | — | — | -US$28.75M | -US$24.71M | — |
| 2023 | — | — | -US$4.03M | -US$4.34M | — |
| 2022 | US$0.05M | — | -US$3.40M | -US$7.25M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.00M | -US$0.70M | — |
| 2026-03-31 | US$0.01M | -US$2.29M | — |
| 2025-12-31 | — | US$5.25M | — |
| 2025-09-30 | US$0.02M | -US$1.47M | — |
| 2025-06-30 | US$0.01M | -US$14.35M | — |
| 2025-03-31 | — | -US$1.27M | — |
| 2024-12-31 | — | -US$27.10M | — |
| 2024-09-30 | — | US$4.25M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.